Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2011-05-31FDA Approved: DONEPEZIL HYDROCHLORIDE — Original Application (Solco Healthcare US, LLC)
FDA approved Solco Healthcare US, LLC's original application for donepezil hydrochloride (generic) tablets. This approval enables use of the…
-
FDA approval · 2011-05-31FDA Approved: DONEPEZIL HYDROCHLORIDE — Original Application (Dr. Reddys Laboratories Limited)
FDA approved the generic donepezil hydrochloride from Dr. Reddys Laboratories Limited via an Original Application for treating Alzheimer's d…
-
FDA approval · 2011-05-31FDA Approved: DONEPEZIL HYDROCHLORIDE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original ANDA for donepezil hydrochloride (generic) from Rising Pharma Holdings, Inc., expanding access to a generic treatm…
-
FDA approval · 2011-05-31FDA Approved: DONEPEZIL HYDROCHLORIDE — Original Application (Torrent Pharmaceuticals Limited)
FDA approves Torrent Pharmaceuticals Limited's donepezil hydrochloride as an original generic application, enabling a generic treatment opti…
-
CLINICAL_TRIALS withdrawal · 2011-05-30Clinical Trial Update: Study of Magnetic Fields to Treat Alzheimer's Disease [NA]
A clinical trial evaluating pico-tesla magnetic field therapy for Alzheimer's disease has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-05-25Clinical Trial Update: Efficacy and Safety of Rivastigmine Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease [Phase 3]
Phase 3 results report on the efficacy and safety of rivastigmine transdermal patch in patients with mild to moderate Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2011-05-24Clinical Trial Update: A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Patients With Hallucinations and Delusions Associated With Alzheimer's Disease [Phase 3]
This Phase 3 trial comparing risperidone to placebo for hallucinations and delusions in Alzheimer's disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2011-05-23Clinical Trial Update: Placebo-Controlled Evaluation of Galantamine in the Treatment of Alzheimer's Disease: Safety and Efficacy of a Controlled-Release Formulation [Phase 3]
A Phase 3 placebo-controlled trial evaluated the safety and efficacy of a controlled-release formulation of galantamine for Alzheimer’s dise…
-
CLINICAL_TRIALS trial_result · 2011-05-20Clinical Trial Update: Safety and Tolerability Study of Extended Release (ER) Galantamine in Alzheimer's Disease [Phase 3]
This is a completed Phase 3 safety and tolerability trial of extended-release galantamine in Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: A Randomized, Double-blind, Flexible Dose, Multicenter Study to Evaluate the Effectiveness and Safety of Galantamine IR in Mild to Moderate Alzheimer's Disease [Phase 3]
A Phase 3 randomized, double-blind trial evaluated the effectiveness and safety of immediate-release galantamine in mild-to-moderate Alzheim…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease [Phase 3]
A Phase 3 trial comparing two doses of galantamine to placebo in Alzheimer's disease has completed, evaluating safety and effectiveness.
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Study of the Safety and Effectiveness of a Flexible Dose of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease [Phase 3]
Phase 3 study comparing a flexible-dose galantamine regimen to placebo in patients with Alzheimer's disease to assess safety and effectivene…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Study of the Safety and Effectiveness of Galantamine Versus Placebo in the Treatment of Patients With Vascular Dementia or Mixed Dementia [Phase 3]
This Phase 3 trial evaluated the safety and effectiveness of galantamine versus placebo in patients with vascular dementia or mixed dementia…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease [Phase 3]
Phase 3 clinical trial comparing two doses of galantamine to placebo in Alzheimer's disease to evaluate safety and effectiveness; the study …
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Cardiac Safety Study of Galantamine in the Treatment of Alzheimer's Disease. [Phase 3]
A Phase 3 cardiac safety study of galantamine for Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease. [Phase 3]
Phase 3 trial evaluating the efficacy and safety of galantamine in patients with Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-13Clinical Trial Update: To Evaluate Effects of AZD1446, Placebo and Donepezil in Patients With Alzheimer's Disease [Phase 2]
A Phase 2 trial evaluating AZD1446 with placebo and donepezil in Alzheimer's disease was terminated.
-
CLINICAL_TRIALS trial_result · 2011-05-11Clinical Trial Update: Exercise Treatment of Mild-Stage Probable Alzheimer's Disease [Phase 2]
A Phase 2 study evaluated exercise treatment for individuals with mild-stage probable Alzheimer's disease; the trial status is completed.
-
CLINICAL_TRIALS research · 2011-04-29Clinical Trial Update: Use of Autobiographical and Interest Assessment for a Better Stimulation of Patients in Nursing Home [NA]
This entry reports on a clinical trial exploring a non-pharmacologic approach using autobiographical and interest assessments to better stim…
-
CLINICAL_TRIALS research · 2011-04-06Clinical Trial Update: Effect of Cognitive Intervention in Alzheimer's Disease (AD) on Functional Cortical Networks in fMRI [Phase 4]
A Phase 4 clinical trial update evaluating a cognitive intervention for Alzheimer's disease and its effects on functional brain networks as …
-
CLINICAL_TRIALS trial_result · 2011-04-06Clinical Trial Update: MRI to Measure Treatment With Antibiotics in Alzheimer's Disease
An update on a completed clinical trial assessing antibiotic treatment for Alzheimer's disease using MRI to measure response.
-
CLINICAL_TRIALS research · 2011-04-06Clinical Trial Update: Computerized Personal Interventions for Alzheimer's Patients [NA]
Clinical trial update on computerized personal interventions for patients with Alzheimer's disease; the current status of the trial is unkno…
-
CLINICAL_TRIALS trial_result · 2011-04-01Clinical Trial Update: Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease [Phase 3]
This Phase 3 trial update reports on the efficacy and safety of donepezil (Aricept) in patients with severe Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2011-04-01Clinical Trial Update: EARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD) [Phase 4]
A Phase 4 trial of donepezil (Aricept) in Hispanic patients with mild to moderate Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2011-03-31Clinical Trial Update: Non-Interventional Study With Aricept® Evess
Pfizer conducted a completed non-interventional study of Aricept Evess (donepezil transdermal patch) for Alzheimer's disease and vascular de…